There is a shortage of Tocilizumab a Covid-19 drug needed by seriously ill patients.The drug increases chances of survival and reduces the need for mechanical ventilation for critically ill Corona virus patients.
The shortage has come at a very critical period since the numbers of infected people are increasing on a daily basis.
Unavailability of the drug makes ICUs and ventilators the only option for these patients yet they are also not enough. Nairobi hospitals' intensive care units are full and most of the patients are in need of oxygen.
The drug is out of stock in most pharmacies and available in some private hospitals but those who managed to buy it had to part with huge amounts of money.
A pharmacist at Kenyatta National Hospital revealed that the pharmacy has not had the drug since last year.
As reported by the Nation, one dosage of Tocilizumab goes for Ksh 200, 000 in a certain private hospital and a patient needs two doses.
Dr Fred Siyoi, the Deputy Registrar at Pharmacy and Poisons Board said that the nations manufacturing the drug are hoarding it for their citizens.
Content created and supplied by: GirlinSpecs (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More